Literature DB >> 15382115

Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.

Matthew T Nichols1, Elsa Gidey, Tom Matzakos, Rolf Dahl, Greg Stiegmann, Raj J Shah, Jared J Grantham, J Gregory Fitz, R Brian Doctor.   

Abstract

The principal extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD) involves formation of liver cysts derived from intrahepatic bile ducts. Autocrine and paracrine factors secreted into the cyst would be positioned to modulate the rate of hepatic cyst growth. The aim of this study was to identify potential growth factors present in human ADPKD liver cyst fluid. Cytokine array and enzyme-linked immunosorbent assay analysis of human ADPKD liver cyst fluid detected epithelial neutrophil attractant 78, interleukin (IL)-6 (503 +/- 121 pg/mL); and IL-8 (4,488 +/- 355 pg/mL); and elevated levels of vascular endothelial growth factor compared with non-ADPKD bile (849 +/- 144 pg/mL vs. 270 pg/mL maximum concentration). ADPKD liver cyst cell cultures also released IL-8 and vascular endothelial growth factor, suggesting that cystic epithelial cells themselves are capable of secreting these factors. Western blotting of cultured cyst cells and immunostaining of intact cysts demonstrate that cysteine-X-cysteine receptor 2, an epithelial neutrophil attractant 78 and IL-8 receptor, is expressed at the apical domain of cyst lining epithelial cells. Suggesting the cystic epithelial cells may exist in hypoxic conditions, electron microscopy of the ADPKD liver cyst epithelium revealed morphological features similar to those observed in ischemic bile ducts. These features include elongation, altered structure, and diminished abundance of apical microvilli. In conclusion, IL-8, epithelial neutrophil attractant 78, IL-6, and vascular endothelial growth factor may serve as autocrine and paracrine factors to direct errant growth of ADPKD liver cyst epithelia. Interruption of these signaling pathways may provide therapeutic targets for inhibiting liver cyst expansion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15382115     DOI: 10.1002/hep.20401

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.

Authors:  Melahat Coban; Ayca Inci
Journal:  Int Urol Nephrol       Date:  2018-04-13       Impact factor: 2.370

3.  Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat.

Authors:  Xiang Shan Ren; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Norihide Yoneda; Zhen Hua Lin; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

Review 4.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 5.  Polycystic liver diseases: advanced insights into the molecular mechanisms.

Authors:  Maria J Perugorria; Tatyana V Masyuk; Jose J Marin; Marco Marzioni; Luis Bujanda; Nicholas F LaRusso; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 46.802

6.  Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.

Authors:  Aura D Urribarri; Patricia Munoz-Garrido; María J Perugorria; Oihane Erice; Maite Merino-Azpitarte; Ander Arbelaiz; Elisa Lozano; Elizabeth Hijona; Raúl Jiménez-Agüero; Maite G Fernandez-Barrena; Juan P Jimeno; Marco Marzioni; Jose J G Marin; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Jesús M Banales
Journal:  Gut       Date:  2014-01-16       Impact factor: 23.059

7.  Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.

Authors:  Monalisa N Muchatuta; Vincent H Gattone; Frank A Witzmann; Bonnie L Blazer-Yost
Journal:  Exp Biol Med (Maywood)       Date:  2008-11-07

8.  Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.

Authors:  Domenico Alvaro; Paolo Onori; Gianfranco Alpini; Antonio Franchitto; Douglas M Jefferson; Alessia Torrice; Vincenzo Cardinale; Fabrizio Stefanelli; Maria Grazia Mancino; Mario Strazzabosco; Mario Angelico; Adolfo Attili; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

Authors:  Jesús M Banales; Tatyana V Masyuk; Pamela S Bogert; Bing Q Huang; Sergio A Gradilone; Seung-Ok Lee; Angela J Stroope; Anatoliy I Masyuk; Juan F Medina; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  Epithelial morphogenesis of MDCK cells in three-dimensional collagen culture is modulated by interleukin-8.

Authors:  Erika K Wells; OrLando Yarborough; Richard P Lifton; Lloyd G Cantley; Michael J Caplan
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-13       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.